While we’re at it

While we’re at it

This news that Sanofi (NYSE: SNY) may well buy Johnson and Johnson (NYSE: JNJ) diabetes device franchise has made us wonder what next. Listen we have been covering this wacky world for 20 plus years and have witnessed some incredibly wacky events but few can top the possibility of Sanofi owning LifeScan and Animas . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.